NASDAQ:LFCR Lifecore Biomedical (LFCR) Stock Price, News & Analysis $4.50 +0.03 (+0.56%) As of 11:20 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Lifecore Biomedical Stock (NASDAQ:LFCR) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Lifecore Biomedical alerts:Sign Up Key Stats Today's Range$4.37▼$4.5250-Day Range$4.09▼$5.0152-Week Range$3.63▼$8.98Volume6,965 shsAverage Volume221,115 shsMarket Capitalization$170.51 millionP/E RatioN/ADividend YieldN/APrice Target$6.50Consensus RatingHold Company Overview Lifecore Biomedical, Inc. is a contract development and manufacturing organization (CDMO) that provides services to pharmaceutical, biotechnology and medical device companies. The company specializes in complex sterile injectable products and supports customers through product development, process development, manufacturing, aseptic filling, packaging and related regulatory services. Lifecore’s capabilities include the production of injectable products using fermentation and other specialized manufacturing processes. The company is also known for its expertise in hyaluronic acid, which is used in pharmaceutical, ophthalmic and medical device applications. Its services are designed to support products from early development through commercial-scale production. The company operates a manufacturing facility in Chaska, Minnesota, and serves customers in the United States and international markets. Lifecore Biomedical was formerly part of Landec Corporation. Following the divestiture of Landec’s food business, Landec changed its name to Lifecore Biomedical in 2023 to reflect its focus on pharmaceutical and life sciences manufacturing.AI Generated. May Contain Errors. Read More Lifecore Biomedical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks27th Percentile Overall ScoreLFCR MarketRank™: Lifecore Biomedical scored higher than 27% of companies evaluated by MarketBeat, and ranked 781st out of 898 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingHold Consensus RatingLifecore Biomedical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and 1 sell rating.Upside PotentialLifecore Biomedical has a consensus price target of $6.50, representing about 45.9% upside from its current price of $4.46.Amount of Analyst CoverageLifecore Biomedical has only been the subject of 2 research reports in the past 90 days.Read more about Lifecore Biomedical's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Lifecore Biomedical are expected to decrease in the coming year, from ($1.02) to ($1.08) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Lifecore Biomedical is -4.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Lifecore Biomedical is -4.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioLifecore Biomedical has a P/B Ratio of 10.61. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Lifecore Biomedical's valuation and earnings. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares Shorted9.51% of the float of Lifecore Biomedical has been sold short.Short Interest Ratio / Days to CoverLifecore Biomedical has a short interest ratio ("days to cover") of 23.19, which indicates bearish sentiment.Change versus previous monthShort interest in Lifecore Biomedical has recently increased by 0.29%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldLifecore Biomedical does not currently pay a dividend.Dividend GrowthLifecore Biomedical does not have a long track record of dividend growth. News and Social Media1.3 / 5News SentimentN/A News SentimentLifecore Biomedical has a news sentiment score of 0.10. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.51 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 1 news article for Lifecore Biomedical this week, compared to 2 articles on an average week. Company Ownership1.4 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Lifecore Biomedical insiders have not sold or bought any company stock.Percentage Held by Insiders32.68% of the stock of Lifecore Biomedical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions83.36% of the stock of Lifecore Biomedical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Lifecore Biomedical's insider trading history. Receive LFCR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lifecore Biomedical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LFCR Stock News HeadlinesContrasting Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF) & Lifecore Biomedical (NASDAQ:LFCR)September 20 at 4:15 AM | americanbankingnews.comLifecore Biomedical: A Messy Balance Sheet, A Much Better BusinessSeptember 14, 2026 | seekingalpha.comA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.September 22 at 1:00 AM | Porter & Company (Ad)Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Lifecore Biomedical (LFCR)September 4, 2026 | theglobeandmail.comLifecore Biomedical to Participate at CPHI Global ConferenceSeptember 3, 2026 | globenewswire.comLifecore Biomedical Adds New Commercial Program, Expands 2028 Revenue Pipeline; Stock UpSeptember 2, 2026 | rttnews.comLifecore Biomedical Signs New Commercial Transfer Agreement for Marketed Injectable ProductSeptember 2, 2026 | quiverquant.comQLifecore Biomedical Signs Agreement for Commercial Site Transfer Supporting Global Pharmaceutical CompanySeptember 2, 2026 | globenewswire.comSee More Headlines LFCR Stock Analysis - Frequently Asked Questions How have LFCR shares performed this year? Lifecore Biomedical's stock was trading at $8.18 at the start of the year. Since then, LFCR shares have decreased by 45.5% and is now trading at $4.4550. How were Lifecore Biomedical's earnings last quarter? Lifecore Biomedical, Inc. (NASDAQ:LFCR) issued its quarterly earnings data on Wednesday, August, 5th. The company reported ($0.19) EPS for the quarter, hitting analysts' consensus estimates of ($0.19). The firm had revenue of $34.17 million for the quarter, compared to analysts' expectations of $34.18 million. Read the conference call transcript. Who are Lifecore Biomedical's major shareholders? Lifecore Biomedical's top institutional shareholders include BlackRock Inc. (5.37%), DCF Advisers LLC (1.12%), Tocqueville Asset Management L.P. (0.40%) and Squarepoint Ops LLC (0.24%). Insiders that own company stock include Wynnefield Partners Small Cap and Paul Josephs. View institutional ownership trends. How do I buy shares of Lifecore Biomedical? Shares of LFCR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Lifecore Biomedical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Lifecore Biomedical investors own include JPMorgan Chase & Co. (JPM), Advanced Micro Devices (AMD), Tesla (TSLA), Meta Platforms (META), NVIDIA (NVDA), Netflix (NFLX) and Visa (V). Company Calendar Last Earnings8/05/2026Today9/22/2026Next Earnings (Estimated)10/02/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (5d) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 As of 5 days ago, LFCR's financial health entered the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:LFCR CIK1005286 Webwww.lifecore.com Phone(952) 368-4300Fax650-368-9818Employees382Year Founded1965Price Target and Rating Average Price Target for Lifecore Biomedical$6.50 High Price Target$6.50 Low Price Target$6.50 Potential Upside/Downside+45.3%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)($1.07) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net Margins-29.93% Pretax MarginN/A Return on EquityN/A Return on Assets-16.16% Debt Debt-to-Equity RatioN/A Current Ratio3.87 Quick Ratio2.69 Sales & Book Value Annual Sales$128.87 million Price / Sales1.31 Cash FlowN/A Price / Cash FlowN/A Book Value$0.42 per share Price / Book10.65Miscellaneous Outstanding Shares37,850,000Free Float25,483,000Market Cap$169.30 million OptionableOptionable Beta1.08 Social Links (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (NASDAQ:LFCR) was last updated on 9/22/2026 by MarketBeat.com Staff. From Our PartnersThe AI Infrastructure Rush Is ON — Watch VDTAVertical Data Inc. (OTCQB: VDTA) is targeting the infrastructure layer beneath the AI boom, from GPU hardware ...Trading Wire | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredA “bloodbath” Is ComingReports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...TradeSmith | SponsoredThe next convergence is hereIn 2006, a flooded mine at Cigar Lake sent uranium prices from the 50 range to 136 in eight months. This pa...Digest Publishing | SponsoredIran War WARNING: Something Just ChangedA powerful Middle Eastern government is reportedly asking Trump for U.S. military help against Iran backed for...Banyan Hill Publishing | SponsoredElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...Brownstone Research | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredWhy is NASA paying Elon to DESTROY a $150 billion space station?NASA is paying Elon Musk's SpaceX up to $843 million to deorbit the $150 billion International Space Station, ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lifecore Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lifecore Biomedical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
